Published in Hepatology on January 01, 2008
Individualized medical decision making: necessary, achievable, but not yet attainable. Arch Intern Med (2010) 2.01
Treatment of portal hypertension. World J Gastroenterol (2012) 1.39
What is most important to patients when deciding about colorectal screening? J Gen Intern Med (2010) 1.17
Clinical pharmacology of portal hypertension. Gastroenterol Clin North Am (2010) 0.92
Beta-blockers in liver cirrhosis. Ann Gastroenterol (2014) 0.90
Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem. Clin Gastroenterol Hepatol (2015) 0.86
Application of endoscopy in improving survival of cirrhotic patients with acute variceal hemorrhage. Int J Hepatol (2011) 0.84
Proximity to disease and perception of utility: physicians' vs patients' assessment of treatment options for ulcerative colitis. Dis Colon Rectum (2011) 0.82
Factors impacting physicians' decisions to prevent variceal hemorrhage. BMC Gastroenterol (2015) 0.78
Recent advances in the management of variceal bleeding. Gastroenterol Rep (Oxf) (2017) 0.76
Endoscopic management of portal hypertension. Int J Hepatol (2012) 0.76
Using conjoint analysis to elicit preferences for health care. BMJ (2000) 7.42
The relationship between method of physician payment and patient trust. JAMA (1998) 5.56
Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ (2001) 4.66
Incorporating patients' preferences into medical decisions. N Engl J Med (1994) 4.21
Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol (2005) 3.68
Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut (1999) 2.98
Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. Gastroenterology (2005) 2.90
How do patients' treatment preferences compare with those of clinicians? Qual Health Care (2001) 2.62
Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology (2004) 2.45
Treatment options in knee osteoarthritis: the patient's perspective. Arch Intern Med (2004) 2.29
Methodological issues in the application of conjoint analysis in health care. Health Econ (1998) 2.15
Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis (1999) 2.15
A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. Liver Transpl (2007) 2.01
Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med (1999) 1.98
A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology (2001) 1.97
Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence. J Acquir Immune Defic Syndr (2004) 1.93
Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc (2004) 1.81
Lack of congruence in the ratings of patients' health status by patients and their physicians. Med Decis Making (2001) 1.75
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Patient preferences for treatment of rheumatoid arthritis. Ann Rheum Dis (2004) 1.47
Endoscopic band ligation in the treatment of portal hypertension. Nat Clin Pract Gastroenterol Hepatol (2005) 1.20
Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatology (Oxford) (2005) 1.18
Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther (2005) 1.14
Measuring patients' medical care preferences: care seeking versus self-treating. Med Decis Making (2001) 0.96
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med (2005) 6.31
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol (2005) 6.22
Vascular disorders of the liver. Hepatology (2009) 5.38
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology (2007) 4.09
Acute-on chronic liver failure. J Hepatol (2012) 3.74
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology (2002) 3.50
Bacterial translocation (BT) in cirrhosis. Hepatology (2005) 3.07
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Hepatology (2005) 2.91
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology (2008) 2.69
Understanding why rheumatoid arthritis patient treatment preferences differ by race. Arthritis Rheum (2009) 2.66
Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis (2008) 2.47
Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis. Liver Int (2010) 2.32
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol (2009) 2.22
Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J Hepatol (2010) 2.16
Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One (2011) 2.11
Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int (2008) 2.10
Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology (2012) 2.01
Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology (2014) 1.89
Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes. J Am Geriatr Soc (2008) 1.79
Recommendations for probiotic use--2008. J Clin Gastroenterol (2008) 1.76
Inconsistency over time in the preferences of older persons with advanced illness for life-sustaining treatment. J Am Geriatr Soc (2007) 1.73
Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology (2011) 1.63
Serum B-type natriuretic peptide in the initial workup of patients with new onset ascites: a diagnostic accuracy study. Hepatology (2014) 1.60
Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review. J Rheumatol (2010) 1.56
Informing patients: the influence of numeracy, framing, and format of side effect information on risk perceptions. Med Decis Making (2010) 1.54
Informed consent for abdominal aortic aneurysm repair: assessing variations in surgeon opinion through a national survey. J Vasc Surg (2008) 1.54
Intensive care of the patient with cirrhosis. Hepatology (2011) 1.54
Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis. J Hepatol (2005) 1.51
Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1. Liver Transpl (2011) 1.44
Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis. Am J Gastroenterol (2004) 1.43
Cost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management. Arch Intern Med (2011) 1.43
Pilot testing of a decision support tool for patients with abdominal aortic aneurysms. J Vasc Surg (2010) 1.42
Treatment of portal hypertension. World J Gastroenterol (2012) 1.39
Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol (2010) 1.36
New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology (2013) 1.35
Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int (2012) 1.29
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay. Hepatology (2008) 1.24
A research agenda for enhancing appropriate opioid prescribing in primary care. J Gen Intern Med (2013) 1.23
Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis. Hepatology (2008) 1.21
Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis? Arthritis Rheumatol (2014) 1.21
Racial disparities in treatment preferences for rheumatoid arthritis. Med Care (2009) 1.21
Patients' preferences for treatment of hepatitis C. Med Decis Making (2009) 1.20
What is most important to patients when deciding about colorectal screening? J Gen Intern Med (2010) 1.17
Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology (2014) 1.16
High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center. Clin Gastroenterol Hepatol (2012) 1.15
Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol (2009) 1.14
Management of gastropathy and gastric vascular ectasia in portal hypertension. Clin Liver Dis (2010) 1.09
Cell death and fibrogenesis. Semin Liver Dis (2010) 1.09
A four-step approach for developing diagnostic tests in psychiatry: EEG in ADHD as a test case. J Neuropsychiatry Clin Neurosci (2005) 1.06
Prevention and treatment of infections in patients with cirrhosis. Best Pract Res Clin Gastroenterol (2007) 1.05
The incidence and natural history of Raynaud's phenomenon in the community. Arthritis Rheum (2005) 1.03
What do patients consider when making decisions about treatment for hepatitis C? Am J Med (2005) 1.03
The management of portal hypertensive gastropathy and gastric antral vascular ectasia. Dig Liver Dis (2010) 1.02
Informed consent for abdominal aortic aneurysm repair: The patient's perspective. J Vasc Surg (2008) 1.02
Use of over-the-counter analgesics is not associated with acute decompensation in patients with cirrhosis. Clin Gastroenterol Hepatol (2009) 1.01
Patients' experiences related to anti-viral treatment for hepatitis C. Patient Educ Couns (2005) 1.01
Factors that influence rheumatologists' decisions to escalate care in rheumatoid arthritis: results from a choice-based conjoint analysis. Arthritis Care Res (Hoboken) (2010) 1.00
Numbers matter to informed patient choices: a randomized design across age and numeracy levels. Med Decis Making (2013) 0.99
Multiple angiomyolipomata of the liver: a case report. Mod Pathol (2002) 0.97
What factors account for referral delays for patients with suspected rheumatoid arthritis? Arthritis Rheum (2006) 0.95
Family planning and contraceptive decision-making by economically disadvantaged, African-American women. Contraception (2012) 0.93
Quantitative histological-hemodynamic correlations in cirrhosis. Hepatology (2012) 0.93
Psychosocial issues in hepatitis C: a qualitative analysis. Psychosomatics (2009) 0.93
Clinical pharmacology of portal hypertension. Gastroenterol Clin North Am (2010) 0.92
Classification of cirrhosis: the clinical use of HVPG measurements. Dis Markers (2011) 0.92
Impact of educational and patient decision aids on decisional conflict associated with total knee arthroplasty. Arthritis Care Res (Hoboken) (2012) 0.92
Acute kidney injury in patients with cirrhosis: perils and promise. Clin Gastroenterol Hepatol (2013) 0.92
Role of magnetic resonance imaging in the diagnosis and prognosis of rheumatoid arthritis. Arthritis Care Res (Hoboken) (2011) 0.90
Use of a computerized order set to increase prescription of calcium and vitamin D supplementation in patients receiving glucocorticoids. J Gen Intern Med (2013) 0.90
Bevacizumab: finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary hemorrhagic telangiectasia. Hepatology (2013) 0.89
Epidemiology of restricting back pain in community-living older persons. J Am Geriatr Soc (2011) 0.88
Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients. Hepatology (2014) 0.88
Liver involvement in hereditary hemorrhagic telangiectasia: CT and clinical findings do not correlate in symptomatic patients. AJR Am J Roentgenol (2006) 0.87
Serum Albumin Can Identify Patients With Compensated Cirrhosis With a Good Prognosis. J Clin Gastroenterol (2015) 0.87
Hepatic vascular malformations in hereditary hemorrhagic telangiectasia. Semin Liver Dis (2008) 0.86
Illness perceptions and fatigue in systemic vasculitis. Arthritis Care Res (Hoboken) (2013) 0.86
Patterns and predictors of treatment initiation and completion in patients with chronic hepatitis C virus infection. Patient Prefer Adherence (2012) 0.86
Restricting back pain and subsequent mobility disability in community-living older persons. J Am Geriatr Soc (2014) 0.85
Bacterial translocation up-regulates GTP-cyclohydrolase I in mesenteric vasculature of cirrhotic rats. Hepatology (2003) 0.85
Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States. Hepatology (2007) 0.84
Sildenafil has no effect on portal pressure but lowers arterial pressure in patients with compensated cirrhosis. Clin Gastroenterol Hepatol (2010) 0.84
Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research. J Pediatr Gastroenterol Nutr (2011) 0.84
Roles of nurse practitioners and physician assistants in rheumatology practices in the US. Arthritis Care Res (Hoboken) (2014) 0.83
Probiotics and liver disease. J Clin Gastroenterol (2008) 0.83
Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls. J Clin Gastroenterol (2013) 0.82
Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: a systematic review. Pain (2013) 0.82
The musculoskeletal diagnosis cohort: examining pain and pain care among veterans. Pain (2016) 0.81
Managing varices: drugs, bands, and shunts. Gastroenterol Clin North Am (2011) 0.81
Pharmacological versus endoscopic therapy in the prevention of variceal hemorrhage: and the winner is... Hepatology (2009) 0.80
Development of a tool for eliciting patient priority from among competing cardiovascular disease, medication-symptoms, and fall injury outcomes. J Am Geriatr Soc (2008) 0.80
A commonsense approach to esophageal varices. Clin Liver Dis (2006) 0.79
Illness representations of restricting back pain: the older Person’s perspective. Pain Med (2014) 0.79
Causal attributions about disease onset and relapse in patients with systemic vasculitis. J Rheumatol (2014) 0.79
Smoking, alcohol consumption, and Raynaud's phenomenon in middle age. Am J Med (2007) 0.79
Hepatic arteriolosclerosis: a small-vessel complication of diabetes and hypertension. Am J Surg Pathol (2015) 0.79
Spontaneous bacterial peritonitis. Rev Gastroenterol Mex (2005) 0.78
Accepting a donor kidney: an evaluation of patients' and transplant surgeons' priorities. Clin Transplant (2010) 0.78
Non-hemorrhagic acute complications associated with cirrhosis and portal hypertension. Best Pract Res Clin Gastroenterol (2013) 0.78